B A Phillips

Author PubWeight™ 63.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Picornaviral structure and assembly. Microbiol Rev 1981 2.93
2 Polyadenylic acid sequences in the virion RNA of poliovirus and Eastern Equine Encephalitis virus. Science 1972 2.78
3 In vitro assembly of poliovirus-related particles. Virology 1968 2.55
4 Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler 2006 1.95
5 Streptococcus garvieae sp. nov. and Streptococcus plantarum sp. nov. J Gen Microbiol 1983 1.91
6 Modulation of the expression of poliovirus proteins in reticulocyte lysates. Virology 1986 1.83
7 Methanethiol production by coryneform bacteria: strains from dairy and human skin sources and Brevibacterium linens. J Gen Microbiol 1977 1.83
8 Taxonomic studies on some group D streptococci. J Gen Microbiol 1983 1.73
9 In vitro assembly of poliovirus. II. Evidence for the self-assembly of 14 S particles into empty capsids. Virology 1971 1.59
10 Dominantly inherited proximal myotonic myopathy and leukoencephalopathy in a family with an incidental CLCN1 mutation. J Neurol Neurosurg Psychiatry 1998 1.44
11 In vitro assembly of polioviruses. I. Kinetics of the assembly of empty capsids and the role of extracts from infected cells. Virology 1969 1.43
12 Comparison of normal saline and heparin solutions for maintenance of arterial catheter patency. Heart Lung 1991 1.42
13 Polypeptide composition of poliovirions, naturally occurring empty capsids, and 14S precursor particles. J Virol 1973 1.31
14 16S rRNA sequence determination for members of the genus Carnobacterium and related lactic acid bacteria and description of Vagococcus salmoninarum sp. nov. Int J Syst Bacteriol 1990 1.24
15 Isometric force-related activity in sensorimotor cortex measured with functional MRI. Exp Brain Res 1998 1.17
16 In vitro assembly of polioviruses. 3. Assembly of 14 S particles into empty capsids by poliovirus-infected HeLa cell membranes. Virology 1973 1.16
17 Glycerol teichoic acid as an antigenic determinant in a Gram-negative bacterium Butyrivibrio fibrisolvens. J Gen Microbiol 1975 1.15
18 Poliovirus empty capsid morphogenesis: evidence for conformational differences between self- and extract-assembled empty capsids. J Virol 1982 1.12
19 What is hypopnea, anyway? Chest 1994 1.11
20 Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol. Influence of mouth rinsing and gargling. Chest 1987 1.09
21 Effect of short-term sleep loss on breathing. J Appl Physiol Respir Environ Exerc Physiol 1982 1.05
22 Physiological studies of the corticomotor projection to the hand after subcortical stroke. Clin Neurophysiol 1999 1.03
23 Premenstrual asthma: the effect of estrogen on symptoms, pulmonary function, and beta 2-receptors. Pharmacotherapy 1997 1.02
24 In vitro assembly of poliovirus. V. Evidence that the self-assembly activity of 14 S particles is independent of extract assembly factor(s) and host proteins. Virology 1978 1.01
25 Long-term changes in motor cortical organisation after recovery from subcortical stroke. Brain Res 2001 0.99
26 Novel mutation in the myelin protein zero gene in a family with intermediate hereditary motor and sensory neuropathy. J Neurol Neurosurg Psychiatry 1999 0.99
27 Effect of sleep position on sleep apnea and parafunctional activity. Chest 1986 0.95
28 Polypeptide composition of urea- and heat-resistant mutants of poliovirus types 1 and 2. J Virol 1974 0.95
29 Differences between poliovirus empty capsids formed in vivo and those formed in vitro: a role for the morphopoietic factor. J Virol 1981 0.95
30 Absence of subviral particles and assembly activity in HeLa cells infected with defective-interfering (DI) particles of poliovirus. Virology 1980 0.93
31 Geriatric sleep apnea syndrome: a preliminary description. J Gerontol 1990 0.93
32 Early onset chromosome 14-linked distal myopathy (Laing). Neuromuscul Disord 2002 0.90
33 Treatment of inflammatory myopathies. Muscle Nerve 1997 0.90
34 The morphogenesis of poliovirus. Curr Top Microbiol Immunol 1972 0.89
35 Differences in functional magnetic resonance imaging of sensorimotor cortex during static and dynamic finger flexion. Exp Brain Res 1999 0.89
36 The effect of sleep loss on breathing in chronic obstructive pulmonary disease. Chest 1987 0.88
37 Effects of dexamethasone on sleep. Pharmacol Toxicol 1996 0.84
38 Efficacy of 1.4 percent sodium citrate in maintaining arterial catheter patency in patients in a medical ICU. Chest 1993 0.84
39 Home monitoring of theophylline levels: a novel therapeutic approach. Pharmacotherapy 1990 0.83
40 The AsTex: clinimetric properties of a new tool for evaluating hand sensation following stroke. Clin Rehabil 2009 0.83
41 Immunoglobulin therapy in inflammatory myopathies. J Neurol Neurosurg Psychiatry 1998 0.83
42 In vitro assembly of polioviruses. IV. Evidence for the existence of two assembly steps in the formation of empty capsids from 14 S particles. Virology 1975 0.83
43 Biological activity and electron microscopy of poliovirus 14S particles obtained from alkali-dissociated procapsids. J Virol 1986 0.82
44 Self report on sleep symptoms in older adults: correlates of daytime sleepiness and health. Sleep 1996 0.81
45 Serological evidence for infection with Campylobacter jejuni/coli in patients with multifocal motor neuropathy. J Clin Neurosci 1998 0.81
46 Human vitreal prostaglandin levels and proliferative diabetic retinopathy. Doc Ophthalmol 2001 0.81
47 A novel method for obtaining poliovirus 14 S pentamers from procapsids and their self-assembly into virus-like shells. Virology 1987 0.80
48 Isocapnic hypoxemia and neuropsychological functioning. J Clin Exp Neuropsychol 1989 0.79
49 Use of temperature-sensitive mutants to study the morphogenesis of poliovirus. Virology 1983 0.79
50 Influence of the cardioprotective agent dexrazoxane on doxorubicin pharmacokinetics in the dog. Cancer Chemother Pharmacol 1992 0.78
51 Idiopathic inflammatory myopathies: optimum immunosuppressive treatment. BioDrugs 1997 0.77
52 Sleep-disordered breathing in healthy aged persons: possible daytime sequelae. J Gerontol 1987 0.77
53 Composition of artificially produced and naturally occurring empty capsids of poliovirus type 1. Virology 1967 0.77
54 Nocturnal bruxing events in subjects with sleep-disordered breathing and control subjects. J Craniomandib Disord 1991 0.77
55 Nocturnal bruxing events in healthy geriatric subjects. J Oral Rehabil 1990 0.76
56 A prospective evaluation of plain radiographic signs of chronic obstructive pulmonary disease. J Thorac Imaging 1991 0.76
57 A reassessment of hilar and mediastinal lymphadenopathy in patients with sarcoidosis. J Ky Med Assoc 1986 0.75
58 Effect of bronchoscopy on localization of gallium-67 citrate. Am Rev Respir Dis 1983 0.75
59 A case of probable thrombotic thrombocytopenic purpura responding to exchange transfusion. Am J Pediatr Hematol Oncol 1982 0.75
60 Synthesis of viral products by cell-free extracts. Prog Med Virol 1971 0.75
61 Sleep-disordered breathing in healthy aged persons: one-year follow-up of daytime sequelae. Sleep 1989 0.75
62 The acute effects of the enkephalin analogue BW 942C in humans. J Clin Pharmacol 1987 0.75
63 A method for freeze drying rumen bacteria and other strict anaerobes. J Appl Bacteriol 1975 0.75
64 A sensitive and specific procedure for quantitation of ADR-529 in biological fluids by high-performance liquid chromatography (HPLC) with column switching and amperometric detection. Pharm Res 1992 0.75
65 The 1989 Kentucky Hospital Smoking Policy Survey. J Ky Med Assoc 1990 0.75
66 Nocturnal bruxing events: a report of normative data and cardiovascular response. J Oral Rehabil 1994 0.75
67 Learning effect of repeated hypercapneic ventilatory response testing. Am J Med Sci 1986 0.75
68 Chronic active hepatitis. J Ky Med Assoc 1971 0.75
69 Catching up on sleep. The National Sleep Disorders Research Plan. Chest 1996 0.75
70 Shoreline inheritance in coastal histories. Science 1977 0.75
71 Acquired Pelger-Huet anomaly in erythroleukemia. J Surg Oncol 1970 0.75
72 Unusual attachment behavior exhibited by a urea-resistant mutant of poliovirus type 1. Virology 1977 0.75
73 Pulmonary function testing: detection of invalid performance. J Ky Med Assoc 1998 0.75
74 Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogs. Biopharm Drug Dispos 1996 0.75